PIN1 and acute lymphoblastic leukemia: Both genetically inhibiting Pin 1 expression or pharmacologically inhibiting Pin 1 activity by ATRA produces potent therapeutic efficacy against ph+ ALL, indicating that Pin1 may act as a new potential target for ph+ ALL therapy.